ZEAL and RPRX Related Headlines

Go Back

Aug 12, 2026 04:07PM Zealand Pharma sells rusfertide royalty rights to Royalty Pharma for $100M
Aug 12, 2026 04:05PM Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide

ZEAL and RPRX Related Press Releases

Go Back

Aug 12, 2026 04:05PM Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide

ZEAL and RPRX Related SEC Filings

Go Back